Jaguar Health, Inc. filed a current report on Form 8-K on November 3, 2026, disclosing that its Series R Convertible Preferred Stock automatically converted into Common Stock on November 2, 2026, resulting in 13,345,986 shares of Common Stock issued and outstanding.

Key Highlights

  • Automatic conversion: On November 2, 2026, each outstanding share of Series R Convertible Preferred Stock automatically converted into five shares of Common Stock, according to the filing.
  • Shares outstanding: Immediately upon completion of the conversion, there were 13,345,986 shares of Common Stock issued and outstanding, the company disclosed.
  • Eligible Warrants: Holders of the Eligible Warrants are entitled to receive, upon exercise, up to 69,823 shares of Common Stock, per the filing.
  • Original dividend: The Series R Preferred Stock Dividend was paid on October 15, 2026, at a rate of one share of Series R Convertible Preferred Stock for each share of voting Common Stock outstanding at the close of business on October 13, 2026.
  • Certificate of Designation: The Series R Certificate of Designation was filed with the Secretary of State of the State of Delaware on October 2, 2026, according to the filing.
  • Warrant share count at dividend: The Eligible Warrants covered, in aggregate, up to 142,535 shares of Common Stock with dividend rights at the time of the original dividend, the filing stated.

Series R Preferred Stock Conversion Details for Jaguar Health

According to the Form 8-K filed by Jaguar Health, Inc. (NASDAQ:JAGX) on November 3, 2026, the company reported that its Series R Convertible Preferred Stock underwent an automatic conversion on November 2, 2026. Each then-outstanding share of Series R Preferred Stock converted into five shares of Common Stock, par value $0.0001 per share, pursuant to the terms of the Series R Certificate of Designation filed with the Delaware Secretary of State on October 2, 2026.

The filing noted that the conversion followed a special one-time dividend paid on October 15, 2026. At that time, the company paid one share of Series R Convertible Preferred Stock for each share of voting Common Stock outstanding, plus each share issuable upon exercise of certain warrants and pre-funded warrants covering, in aggregate, up to 142,535 shares of Common Stock with dividend rights. The record date for that dividend was October 13, 2026.

The company disclosed that immediately upon completion of the conversion, there were 13,345,986 shares of Common Stock issued and outstanding. Additionally, holders of the Eligible Warrants are entitled to receive, upon exercise, up to 69,823 shares of Common Stock, which the filing described as including the Warrant Shares and shares of Common Stock from the dividend of Series O Convertible Preferred Stock and the Series R Preferred Stock Dividend. The report was signed by Lisa A. Conte, President and Chief Executive Officer, on November 3, 2026.

What Was Disclosed

Jaguar Health disclosed the November 2, 2026, automatic conversion of its Series R Convertible Preferred Stock into Common Stock at a ratio of five shares of Common Stock per preferred share, resulting in 13,345,986 shares of Common Stock issued and outstanding immediately after the conversion.